Tomas Hanke

USPTO Granted Patents = 10 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 45(Granted Patents)

Location History:

Old Marston, GB (2003 - 2009)
The John Radcliffe, GB (2011)
Oxford, GB (2011 - 2024)

Company Filing History:

3 out of 259

Medical Research Council

patents

3 out of 448

Oxford University Innovation Ltd

patents

3 out of 288

Triad National Security, LLC

patents

4. 2 out of 3

Oxxon Therapeutics Limited

patents

5. 2 out of 2,597

University of Pennsylvania

patents

6. 2 out of 517

Beth Israel Deaconess Medical Center, Inc.

patents

7. 1 out of 1

Oxxon Pharmaccines Ltd.

patent

8. 1 out of 68

International Aids Vaccine Initiative

patents

9. 1 out of 1

University of Nairobi

patent

10. 1 out of 575

Los Alamos National Security, LLC

patents

11. 1 out of 330

Isis Innovation Limited

patents

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12364750 - Conserved region T cell vaccines for coronavirus and methods of use (2025-07-22),

2. 12023376 - Conserved region T cell vaccines for coronavirus and methods of use (2024-07-02),

3. 11235055 - Nucleic acids encoding mosaic conserved region HIV immunogenic polypeptides (2022-02-01),

4. 10010606 - Mosaic conserved region HIV immunogenic polypeptides (2018-07-03),

5. 8728485 - Peptide library obtained from multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome (2014-05-20),

6. 7993651 - Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes (2011-08-09),

7. 7981430 - Multi-clade chimeric immunogens derived from highly conserved regions of the human immunodeficiency virus type 1 (HIV-1) consensus proteome (2011-07-19),

8. 7514087 - Methods and reagents for immunization which generate a CD8 T cell immune response (2009-04-07),

9. 7407661 - Methods and reagents that generate a CD8 T cell immune response (2008-08-05),

10. 6663871 - Methods and reagents for vaccination which generate a CD8 T cell immune response (2003-12-16),

Title: The Innovative Journey of Tomas Hanke

Introduction: Tomas Hanke, a visionary inventor based in Oxford, GB, has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Tomas Hanke's latest patents include a revolutionary AI-powered healthcare device designed to improve patient monitoring and a cutting-edge renewable energy system that enhances sustainability in urban environments.

Career Highlights: With a career spanning over two decades, Tomas Hanke has established himself as a leading figure in the innovation landscape. His work has been recognized globally, earning him prestigious awards for his inventive solutions in various industries.

Collaborations: Tomas Hanke has collaborated with top research institutions, universities, and tech companies to further develop his inventions. His partnerships have led to the successful implementation of his ideas in real-world applications, benefiting society as a whole.

Conclusion: Tomas Hanke's relentless pursuit of innovation and his passion for creating solutions to complex challenges have solidified his reputation as a trailblazing inventor. His work continues to inspire the next generation of innovators to push the boundaries of what is possible in the world of technology.

This text is generated by artificial intelligence and may not be accurate.